Regression modelling revealed that C3, C3b, C4b, C5, C5a and C1q were associated with increased risk of unfavorable outcomes in unadjusted and adjusted analyses in the study cohort.<h4>Discussion</h4>These findings suggest that early and sustained complement activation, particularly through the classical pathway, is associated with adverse outcomes in TB. This evidence concerns the gene C5 and tuberculosis.